Abstract:Objective. To observe the changes of serum adiponectin (AP) levels in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and explore the correlation between serum AP and polysomnography (PSG) parameters in patients with OSAHS. Methods. The data of subjects who underwent PSG at the hospital between January 2021 and December 2022 were collected retrospectively and divided into simple snoring group (AHI < 5 times/h, n = 45), mild OSAHS group (5 ≤ AHI 30 times/h, n = 60). The general data, PSG indices, and serological indices of the subjects were collected and compared between groups. Pearson correlation analysis and partial correlation analysis were employed to examine the correlation between serum AP level and PSG parameters. Ordered logistic regression was employed to analyze the risk factors influencing the severity of OSAHS. The predictive capability of the serum AP level in determining the occurrence of OSAHS was assessed using ROC. The serum AP levels of subjects with different subtypes of PSG indicators were compared. Results. In the simple snoring group, mild OSAHS group, moderate OSAHS group, and severe OSAHS group, there were statistically significant differences in microarousal count, MAI, AHI, times of blood oxygen decreased by ≥ 3%, L-SaO2, and TS90% among the 4 groups ( P < 0.05 ). The level of serum AP was positively correlated with L-SaO2 and negatively correlated with the proportion of REM, microarousal count, MAI, AHI, times of blood oxygen decreased by ≥ 3%, TS90%, and LP ( P < 0.05 ). High AHI was a risk factor affecting the severity of OSAHS (95% CI: 1.446–4.170). The AUC of serum AP level in diagnosing OSAHS was 0.906 (95% CI: 0.8601–0.9521), and when the Youden Index was 0.678, the sensitivity was 88.9%, and the specificity was 78.9% ( P < 0.0001 ). In the population with a high microarousal count, high AHI, and high times of blood oxygen decreased by ≥ 3% and high TS90%, the serum AP level was lower than that in the low-level population ( P < 0.05 ). In the population with high L-SaO2, the serum AP level was higher than that in low-level population ( P < 0.05 ). Conclusion. The level of serum AP decreased with the increase of the disease severity of patients with OSAHS and demonstrates a significant predictive capability for the occurrence of OSAHS. Monitoring the level of serum AP can effectively forecast the risk of OSAHS. Furthermore, alterations in serum AP levels are associated with both hypoxemia and a heightened frequency of arousal in patients with OSAHS.

Plasma Expression of HIF‐1α As Novel Biomarker for the Diagnosis of Obstructive Sleep Apnea‐hypopnea Syndrome

Plasma APRIL as a Potential Biomarker in the Diagnosis of Obstructive Sleep Apnea

The activated pathways by hypoxia in patients with Obstructive sleep apnea hypopnea syndrome

Changes of Serum Adiponectin Level in Patients with Obstructive Sleep Apnea Hypopnea Syndrome and Its Relationship with Sleep Monitoring Indexes

Plasma tRF-16-79MP9PD and tRF-28-OB1690PQR304 as potential biomarkers for 4- to 7-year-old children with obstructive sleep apnea-hypopnea syndrome

Relationship of redundant Th17 cells and IL-17A, but not IL-17 F, with the severity of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)

Evaluating the clinical value of the hypoxia burden index in patients with obstructive sleep apnea.

Relationship between HIF-1 and Circadian Clock Proteins in Obstructive Sleep Apnea Patients—Preliminary Study

The correlation of serum/plasma IGF-1 concentrations with obstructive sleep apnea hypopnea syndrome: A meta-analysis and meta-regression

In-depth proteomics and Phosphoproteomics reveal biomarkers and molecular pathways of chronic intermittent hypoxia in mice

Quantification of Circulating Cell-Free DNA in the Serum of Patients with Obstructive Sleep Apnea–Hypopnea Syndrome

Application of Ischemia Modified Albumin in the Diagnosis and Treatment of Obstructive Sleep Apnea Syndrome

Changes of Plasma C-reactive Protein, Endothelin-1 and Tumor Necrosis Factor-Α in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

[CD69 Expression on T Cell Surface in Patients with Obstructive Sleep Apnea Hypopnea Syndrome].

Value of Pulse Oximetry for Diagnosing Obstructive Sleep Apnea-Hypopnea Syndrome and Evaluation of the Effect of the Continuous Positive Airway Pressure Therapy

The Discovery, Validation, and Function of Hypoxia-Related Gene Biomarkers for Obstructive Sleep Apnea

Feasibility of screening and diagnosing obstructive sleep apnea-hypopnea syndrome by oxygen desaturation index and its association with nighttime blood pressure

The Predictive Value of Plasma Thioredoxin Level for Obstructive Sleep Apnea-Hypopnea Syndrome

Biomarkers and Dynamic Cerebral Autoregulation of Obstructive Sleep Apnea-Hypopnea Syndrome

Nocturnal oximetry saturation monitoring combined with clinical score in preliminary screening of obstructive sleep apnea hypopnea syndrome

Study about the change of lipid metabolism in patients of obstructive sleep apneahypopnea syndrome